Keith Ferdinand Chief Science Officer of the Association of Black Cardiology.
RAND researchers examined the methods of using the insurance to be responsible for the cost of care when a patient sees multiple doctors dismissed. Developed developed ‘attribution ‘attribution rules ‘the responsibility for the costs of care on patterns derived from health care claims.
Funding for the study by the by the U.S. Department of Labor are available. Other authors of the study are John. Adams and Elizabeth A. McGlynn of RAND and J. William Thomas of the University of Southern Maine.Factor behind slow distribution lot of doctors say that the drug is marketing to backward conversion in part because BiDil is specifically as a drug for blacks. Keith Ferdinand – Chief Science Officer of the Association of Black Cardiology, who completed the study that led BiDil consent Co in – sponsorship – says his questions whether the medication had to have more success when toward in the direction the general people, so specific effect the Black available on its own. .
NitroMed official saying that despite disappointing BiDil sales, it are developing of the drug continues and noticed that BiDil is not performance impede tomorrow racism specific drug drugs Kenneth Bate, NitroMed president and CEO, said, with every new drug, it was a gradual process (Newark Star-Ledger.